Gene Symbol | Gene ID | Gene Info |
---|---|---|
Onecut1
|
ENSMUSG00000043013.9 | one cut domain, family member 1 |
Cux2
|
ENSMUSG00000042589.12 | cut-like homeobox 2 |
Cux2
|
ENSMUSG00000072641.1 | cut-like homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_122046438_122047002 | Cux2 | 1105 | 0.369788 | 0.69 | 1.2e-09 | Click! |
chr5_122047558_122047709 | Cux2 | 192 | 0.845978 | 0.64 | 4.2e-08 | Click! |
chr5_122047844_122047995 | Cux2 | 28 | 0.884886 | 0.62 | 1.6e-07 | Click! |
chr5_121925225_121926346 | Cux2 | 864 | 0.584708 | 0.62 | 1.7e-07 | Click! |
chr5_122062335_122063154 | Cux2 | 12642 | 0.131585 | -0.45 | 3.6e-04 | Click! |
chr9_74865733_74868961 | Onecut1 | 863 | 0.537443 | 0.58 | 1.1e-06 | Click! |
chr9_74864280_74865379 | Onecut1 | 1655 | 0.304585 | 0.40 | 1.3e-03 | Click! |
chr9_74861883_74864045 | Onecut1 | 1043 | 0.453318 | 0.40 | 1.7e-03 | Click! |
chr9_74865394_74865680 | Onecut1 | 947 | 0.496480 | 0.38 | 2.8e-03 | Click! |
chr9_74869680_74869831 | Onecut1 | 3271 | 0.196115 | 0.30 | 1.8e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_83722679_83723219 | 6.76 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1568 |
0.29 |
chr8_108537198_108537924 | 6.76 |
Gm39244 |
predicted gene, 39244 |
340 |
0.92 |
chr12_29531656_29532106 | 5.49 |
Gm20208 |
predicted gene, 20208 |
766 |
0.61 |
chr15_25754845_25755428 | 5.20 |
Myo10 |
myosin X |
2157 |
0.37 |
chr2_181766837_181767244 | 5.17 |
Myt1 |
myelin transcription factor 1 |
2 |
0.97 |
chr3_17792584_17792950 | 4.86 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1153 |
0.46 |
chr17_91090702_91091377 | 4.72 |
Nrxn1 |
neurexin I |
1694 |
0.28 |
chr3_102010214_102010759 | 4.58 |
Nhlh2 |
nescient helix loop helix 2 |
331 |
0.89 |
chr9_41578714_41578969 | 4.58 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
653 |
0.53 |
chr18_25749825_25750329 | 4.45 |
Celf4 |
CUGBP, Elav-like family member 4 |
2615 |
0.33 |
chr17_91091821_91092017 | 4.15 |
Nrxn1 |
neurexin I |
814 |
0.55 |
chr3_4796861_4798079 | 4.15 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
88 |
0.98 |
chr11_34315414_34316667 | 4.06 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr4_45824039_45824548 | 3.96 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
2630 |
0.22 |
chr6_103510606_103512502 | 3.94 |
Chl1 |
cell adhesion molecule L1-like |
224 |
0.93 |
chr5_66678971_66679451 | 3.93 |
Uchl1 |
ubiquitin carboxy-terminal hydrolase L1 |
2319 |
0.2 |
chr9_108824114_108825614 | 3.89 |
Gm35025 |
predicted gene, 35025 |
3 |
0.87 |
chr9_75682602_75682827 | 3.89 |
Scg3 |
secretogranin III |
873 |
0.53 |
chr1_146494200_146495557 | 3.74 |
Gm29514 |
predicted gene 29514 |
73 |
0.56 |
chr3_88208985_88210116 | 3.72 |
Gm3764 |
predicted gene 3764 |
78 |
0.92 |
chr14_64588312_64589438 | 3.71 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
341 |
0.81 |
chr8_109378550_109379871 | 3.57 |
Gm1943 |
predicted gene 1943 |
38346 |
0.16 |
chr13_99445913_99446157 | 3.54 |
Map1b |
microtubule-associated protein 1B |
1568 |
0.39 |
chr10_92404661_92405130 | 3.46 |
4930401A07Rik |
RIKEN cDNA 4930401A07 gene |
3881 |
0.24 |
chr3_108153841_108154889 | 3.42 |
Gpr61 |
G protein-coupled receptor 61 |
517 |
0.6 |
chr3_8512495_8512918 | 3.40 |
Stmn2 |
stathmin-like 2 |
3120 |
0.28 |
chr9_75681964_75682559 | 3.39 |
Scg3 |
secretogranin III |
1326 |
0.37 |
chrX_143929366_143930062 | 3.38 |
Dcx |
doublecortin |
3336 |
0.34 |
chr2_6881042_6881689 | 3.38 |
Gm13389 |
predicted gene 13389 |
2905 |
0.24 |
chr7_62365449_62365672 | 3.36 |
Magel2 |
melanoma antigen, family L, 2 |
11450 |
0.17 |
chr8_31917541_31918367 | 3.33 |
Nrg1 |
neuregulin 1 |
288 |
0.81 |
chr6_13835523_13837039 | 3.28 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr4_13754294_13755025 | 3.24 |
Runx1t1 |
RUNX1 translocation partner 1 |
3362 |
0.37 |
chr2_6883618_6884699 | 3.24 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr14_25610327_25611867 | 3.22 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
3259 |
0.25 |
chr2_38342005_38342312 | 3.19 |
Lhx2 |
LIM homeobox protein 2 |
1066 |
0.44 |
chr7_128690432_128691249 | 3.15 |
Gm16044 |
predicted gene 16044 |
1849 |
0.17 |
chr16_77646908_77647363 | 3.11 |
C130023A14Rik |
RIKEN cDNA C130023A14 gene |
795 |
0.35 |
chr7_60002794_60003146 | 3.11 |
Snurf |
SNRPN upstream reading frame |
2079 |
0.12 |
chr13_36613015_36613742 | 3.10 |
Gm46409 |
predicted gene, 46409 |
406 |
0.82 |
chr15_92160888_92162023 | 3.08 |
Cntn1 |
contactin 1 |
98 |
0.98 |
chr4_142292610_142292761 | 3.02 |
Kazn |
kazrin, periplakin interacting protein |
53284 |
0.13 |
chr13_78193022_78193812 | 2.99 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
2956 |
0.18 |
chr6_112945034_112945954 | 2.98 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
1260 |
0.31 |
chr11_94046147_94046506 | 2.95 |
Spag9 |
sperm associated antigen 9 |
1961 |
0.31 |
chrX_88113433_88114223 | 2.90 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
1817 |
0.46 |
chr13_8205494_8206737 | 2.88 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
3193 |
0.23 |
chr9_75683375_75684591 | 2.85 |
Scg3 |
secretogranin III |
8 |
0.97 |
chr1_50930259_50930410 | 2.84 |
Tmeff2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
2815 |
0.31 |
chrX_110818058_110818665 | 2.82 |
Pou3f4 |
POU domain, class 3, transcription factor 4 |
4081 |
0.27 |
chr16_13357876_13359918 | 2.77 |
Mrtfb |
myocardin related transcription factor B |
476 |
0.83 |
chr1_99772154_99773556 | 2.75 |
Cntnap5b |
contactin associated protein-like 5B |
90 |
0.98 |
chr5_26906947_26907198 | 2.73 |
Dpp6 |
dipeptidylpeptidase 6 |
2377 |
0.36 |
chr1_109984209_109985108 | 2.72 |
Cdh7 |
cadherin 7, type 2 |
921 |
0.74 |
chr1_42691569_42692627 | 2.72 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
995 |
0.42 |
chr9_91350199_91351559 | 2.66 |
A730094K22Rik |
RIKEN cDNA A730094K22 gene |
74 |
0.95 |
chr4_109342938_109343450 | 2.66 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
59 |
0.97 |
chr8_54957303_54957776 | 2.62 |
Gm45263 |
predicted gene 45263 |
2280 |
0.24 |
chr10_111247804_111248910 | 2.59 |
Osbpl8 |
oxysterol binding protein-like 8 |
289 |
0.91 |
chr5_37241461_37244349 | 2.57 |
Crmp1 |
collapsin response mediator protein 1 |
171 |
0.95 |
chr2_37516828_37517574 | 2.51 |
Gpr21 |
G protein-coupled receptor 21 |
575 |
0.47 |
chr15_63532309_63532947 | 2.50 |
Gm4942 |
predicted gene 4942 |
40335 |
0.14 |
chr10_64089736_64090806 | 2.47 |
Lrrtm3 |
leucine rich repeat transmembrane neuronal 3 |
3 |
0.99 |
chr17_29883165_29884481 | 2.46 |
Mdga1 |
MAM domain containing glycosylphosphatidylinositol anchor 1 |
3659 |
0.2 |
chrX_143930842_143933141 | 2.45 |
Dcx |
doublecortin |
1059 |
0.64 |
chr11_79592762_79592947 | 2.45 |
Rab11fip4 |
RAB11 family interacting protein 4 (class II) |
1642 |
0.23 |
chr11_102394791_102396113 | 2.44 |
Rundc3a |
RUN domain containing 3A |
2049 |
0.17 |
chr1_88698575_88698781 | 2.42 |
Arl4c |
ADP-ribosylation factor-like 4C |
3198 |
0.22 |
chr13_56895147_56895774 | 2.38 |
Trpc7 |
transient receptor potential cation channel, subfamily C, member 7 |
277 |
0.94 |
chr17_52601836_52601987 | 2.34 |
Gm27217 |
predicted gene 27217 |
749 |
0.46 |
chr14_39469812_39470401 | 2.32 |
Nrg3 |
neuregulin 3 |
2560 |
0.44 |
chr1_143641893_143642230 | 2.28 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
464 |
0.75 |
chr2_22624675_22625045 | 2.27 |
Gad2 |
glutamic acid decarboxylase 2 |
1556 |
0.29 |
chr5_116589538_116590511 | 2.27 |
Srrm4 |
serine/arginine repetitive matrix 4 |
1793 |
0.34 |
chr12_49389323_49389516 | 2.23 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
233 |
0.89 |
chr14_77159311_77160431 | 2.23 |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
3091 |
0.31 |
chr6_55680133_55680881 | 2.22 |
Neurod6 |
neurogenic differentiation 6 |
756 |
0.69 |
chr12_74285521_74285936 | 2.22 |
1700086L19Rik |
RIKEN cDNA 1700086L19 gene |
1439 |
0.35 |
chr14_68126289_68127413 | 2.20 |
Nefm |
neurofilament, medium polypeptide |
2005 |
0.3 |
chr5_88588676_88589297 | 2.19 |
Rufy3 |
RUN and FYVE domain containing 3 |
5192 |
0.18 |
chr14_55057067_55057894 | 2.19 |
Gm20687 |
predicted gene 20687 |
1987 |
0.14 |
chr3_118674266_118674774 | 2.17 |
Dpyd |
dihydropyrimidine dehydrogenase |
112334 |
0.06 |
chr2_32428080_32429746 | 2.16 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1839 |
0.19 |
chr3_107114280_107114523 | 2.15 |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
11719 |
0.15 |
chr1_124042617_124042950 | 2.15 |
Dpp10 |
dipeptidylpeptidase 10 |
2380 |
0.44 |
chr12_72234504_72235243 | 2.13 |
Rtn1 |
reticulon 1 |
866 |
0.66 |
chr12_49377594_49378099 | 2.11 |
Gm34304 |
predicted gene, 34304 |
4039 |
0.16 |
chr16_75446445_75446739 | 2.10 |
Gm49678 |
predicted gene, 49678 |
701 |
0.76 |
chr8_93810943_93811954 | 2.10 |
Gnao1 |
guanine nucleotide binding protein, alpha O |
135 |
0.93 |
chr4_33926104_33927188 | 2.09 |
Cnr1 |
cannabinoid receptor 1 (brain) |
444 |
0.88 |
chr14_80901423_80902185 | 2.08 |
Gm49044 |
predicted gene, 49044 |
28933 |
0.21 |
chr12_52702153_52702917 | 2.08 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
3152 |
0.28 |
chrX_6169933_6171264 | 2.06 |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
2417 |
0.31 |
chr15_92162506_92162673 | 2.05 |
Cntn1 |
contactin 1 |
1232 |
0.61 |
chr5_5264770_5266186 | 2.02 |
Cdk14 |
cyclin-dependent kinase 14 |
169 |
0.96 |
chr1_185455922_185456264 | 2.01 |
Gm2061 |
predicted gene 2061 |
525 |
0.59 |
chr5_122047844_122047995 | 2.01 |
Cux2 |
cut-like homeobox 2 |
28 |
0.88 |
chr5_15937662_15938665 | 2.01 |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
3252 |
0.2 |
chr15_39392623_39392878 | 2.01 |
Rims2 |
regulating synaptic membrane exocytosis 2 |
950 |
0.68 |
chrX_13843472_13844167 | 2.00 |
Cask |
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
2269 |
0.41 |
chr7_64855942_64856628 | 2.00 |
Fam189a1 |
family with sequence similarity 189, member A1 |
112 |
0.97 |
chr15_25758674_25760120 | 1.98 |
Myo10 |
myosin X |
612 |
0.78 |
chr6_105676979_105678296 | 1.97 |
Cntn4 |
contactin 4 |
23 |
0.52 |
chr12_48959435_48959914 | 1.97 |
Gm26454 |
predicted gene, 26454 |
50209 |
0.16 |
chr4_125493964_125494986 | 1.97 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
3775 |
0.23 |
chr7_65154721_65155254 | 1.95 |
Fam189a1 |
family with sequence similarity 189, member A1 |
1429 |
0.4 |
chr16_59409330_59409716 | 1.95 |
Gabrr3 |
gamma-aminobutyric acid (GABA) receptor, rho 3 |
2191 |
0.25 |
chr15_95525022_95525792 | 1.94 |
Nell2 |
NEL-like 2 |
2771 |
0.35 |
chr16_77645925_77646470 | 1.94 |
Mir125b-2 |
microRNA 125b-2 |
76 |
0.58 |
chr16_45406866_45407017 | 1.91 |
Cd200 |
CD200 antigen |
1923 |
0.28 |
chr5_65175643_65176386 | 1.90 |
Klhl5 |
kelch-like 5 |
19944 |
0.14 |
chrX_57766985_57767599 | 1.88 |
Gm14631 |
predicted gene 14631 |
13424 |
0.18 |
chr12_107997791_107998940 | 1.86 |
Bcl11b |
B cell leukemia/lymphoma 11B |
5049 |
0.31 |
chr16_81203792_81204456 | 1.85 |
Ncam2 |
neural cell adhesion molecule 2 |
3367 |
0.33 |
chr2_70561239_70561739 | 1.85 |
Gad1 |
glutamate decarboxylase 1 |
553 |
0.66 |
chr13_99513069_99513554 | 1.84 |
Map1b |
microtubule-associated protein 1B |
3207 |
0.2 |
chr12_107999037_107999696 | 1.84 |
Bcl11b |
B cell leukemia/lymphoma 11B |
4048 |
0.33 |
chr17_42317813_42318153 | 1.83 |
Ptchd4 |
patched domain containing 4 |
1383 |
0.61 |
chr12_3371810_3372179 | 1.83 |
Gm48511 |
predicted gene, 48511 |
3565 |
0.16 |
chr10_57784547_57786586 | 1.82 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr12_84698972_84699195 | 1.80 |
Syndig1l |
synapse differentiation inducing 1 like |
252 |
0.9 |
chr11_116411041_116411192 | 1.80 |
Rnf157 |
ring finger protein 157 |
1888 |
0.21 |
chr14_122484799_122486138 | 1.79 |
Gm10837 |
predicted gene 10837 |
5118 |
0.12 |
chr12_118850516_118850667 | 1.79 |
Sp8 |
trans-acting transcription factor 8 |
3005 |
0.29 |
chr10_119693999_119694361 | 1.78 |
Grip1 |
glutamate receptor interacting protein 1 |
2126 |
0.34 |
chr13_109445560_109445945 | 1.78 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
3569 |
0.38 |
chr1_78186833_78187893 | 1.77 |
Pax3 |
paired box 3 |
9475 |
0.23 |
chr18_64265796_64267074 | 1.77 |
St8sia3 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 |
47 |
0.97 |
chr6_32583482_32584367 | 1.77 |
Plxna4 |
plexin A4 |
4268 |
0.26 |
chr11_97841566_97842003 | 1.77 |
B230217C12Rik |
RIKEN cDNA B230217C12 gene |
465 |
0.67 |
chr14_121738221_121738727 | 1.77 |
Dock9 |
dedicator of cytokinesis 9 |
387 |
0.9 |
chr3_38894285_38895428 | 1.76 |
Fat4 |
FAT atypical cadherin 4 |
3914 |
0.27 |
chr6_40431094_40431562 | 1.75 |
Dennd11 |
DENN domain containing 11 |
80 |
0.96 |
chr9_91348867_91349403 | 1.74 |
A730094K22Rik |
RIKEN cDNA A730094K22 gene |
1818 |
0.21 |
chr13_18580997_18581295 | 1.74 |
Gm48829 |
predicted gene, 48829 |
64203 |
0.13 |
chr9_35427115_35427995 | 1.73 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
3967 |
0.19 |
chr9_41582824_41584205 | 1.72 |
Mir125b-1 |
microRNA 125b-1 |
1588 |
0.2 |
chr15_16729545_16729850 | 1.72 |
Cdh9 |
cadherin 9 |
941 |
0.71 |
chr15_98971157_98971748 | 1.72 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
11896 |
0.08 |
chr7_97842700_97844158 | 1.69 |
Pak1 |
p21 (RAC1) activated kinase 1 |
494 |
0.83 |
chr12_69149864_69150387 | 1.68 |
Gm24499 |
predicted gene, 24499 |
2252 |
0.11 |
chr11_93098807_93100169 | 1.67 |
Car10 |
carbonic anhydrase 10 |
198 |
0.97 |
chr2_170734259_170734932 | 1.66 |
Dok5 |
docking protein 5 |
2788 |
0.35 |
chr2_124093375_124093526 | 1.66 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
3481 |
0.33 |
chr4_24429901_24430719 | 1.65 |
Gm27243 |
predicted gene 27243 |
580 |
0.79 |
chr4_82499658_82501360 | 1.65 |
Nfib |
nuclear factor I/B |
1193 |
0.5 |
chr6_94681402_94682604 | 1.65 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
1373 |
0.5 |
chr1_115686481_115687365 | 1.65 |
Cntnap5a |
contactin associated protein-like 5A |
2167 |
0.34 |
chr14_84446582_84446935 | 1.64 |
Pcdh17 |
protocadherin 17 |
1749 |
0.43 |
chr14_54475593_54477091 | 1.64 |
Rem2 |
rad and gem related GTP binding protein 2 |
90 |
0.93 |
chr12_29526477_29526710 | 1.64 |
Myt1l |
myelin transcription factor 1-like |
1791 |
0.41 |
chr1_177448882_177449429 | 1.64 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
3334 |
0.19 |
chr13_63627159_63628101 | 1.64 |
Gm30709 |
predicted gene, 30709 |
251 |
0.9 |
chr7_92234907_92236280 | 1.63 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr12_27064608_27065073 | 1.63 |
Gm9866 |
predicted gene 9866 |
50155 |
0.18 |
chrX_110812404_110812672 | 1.62 |
Gm44593 |
predicted gene 44593 |
214 |
0.93 |
chr17_48999728_48999879 | 1.62 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
67424 |
0.11 |
chr14_122376364_122377232 | 1.61 |
Gm25464 |
predicted gene, 25464 |
11362 |
0.18 |
chr9_74277842_74278196 | 1.60 |
Wdr72 |
WD repeat domain 72 |
3885 |
0.32 |
chr9_117870768_117871285 | 1.60 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
1558 |
0.39 |
chr12_118852025_118852421 | 1.59 |
Sp8 |
trans-acting transcription factor 8 |
4637 |
0.25 |
chr12_29537800_29538885 | 1.59 |
Myt1l |
myelin transcription factor 1-like |
3120 |
0.28 |
chr12_27336880_27337279 | 1.59 |
Sox11 |
SRY (sex determining region Y)-box 11 |
5495 |
0.31 |
chr3_89224304_89224455 | 1.58 |
Thbs3 |
thrombospondin 3 |
49 |
0.91 |
chr5_20227904_20228343 | 1.57 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
63 |
0.98 |
chr8_84769068_84769679 | 1.57 |
Nfix |
nuclear factor I/X |
4023 |
0.13 |
chr8_111540226_111540558 | 1.57 |
Znrf1 |
zinc and ring finger 1 |
867 |
0.59 |
chr13_72815978_72817181 | 1.56 |
D730050B12Rik |
RIKEN cDNA D730050B12 gene |
184 |
0.96 |
chrX_163910829_163911486 | 1.55 |
Ap1s2 |
adaptor-related protein complex 1, sigma 2 subunit |
244 |
0.94 |
chr9_107401822_107402928 | 1.55 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
2306 |
0.19 |
chr11_113198287_113199278 | 1.55 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
3040 |
0.32 |
chr13_52528312_52528571 | 1.54 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
2838 |
0.37 |
chr9_41329234_41329422 | 1.54 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
562 |
0.75 |
chr18_79105753_79105904 | 1.53 |
Setbp1 |
SET binding protein 1 |
3563 |
0.35 |
chr5_66678440_66678918 | 1.53 |
Uchl1 |
ubiquitin carboxy-terminal hydrolase L1 |
1787 |
0.24 |
chr13_53077848_53078081 | 1.53 |
Gm48336 |
predicted gene, 48336 |
49046 |
0.14 |
chr7_24948719_24949186 | 1.53 |
Erfl |
ETS repressor factor like |
4458 |
0.1 |
chr5_114090407_114091746 | 1.53 |
Svop |
SV2 related protein |
291 |
0.84 |
chr10_122044028_122044179 | 1.53 |
Srgap1 |
SLIT-ROBO Rho GTPase activating protein 1 |
3205 |
0.2 |
chr7_34773545_34773841 | 1.52 |
Chst8 |
carbohydrate sulfotransferase 8 |
19881 |
0.2 |
chr3_5222045_5223052 | 1.52 |
Zfhx4 |
zinc finger homeodomain 4 |
1043 |
0.46 |
chrX_133684830_133685971 | 1.51 |
Pcdh19 |
protocadherin 19 |
409 |
0.91 |
chr19_38263947_38265363 | 1.50 |
Lgi1 |
leucine-rich repeat LGI family, member 1 |
5 |
0.97 |
chr13_83732205_83734272 | 1.49 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr3_17793835_17795104 | 1.49 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
427 |
0.75 |
chr13_84756855_84757289 | 1.48 |
Gm26913 |
predicted gene, 26913 |
66131 |
0.14 |
chr9_58203042_58203248 | 1.48 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
194 |
0.54 |
chr6_4744567_4744778 | 1.47 |
Sgce |
sarcoglycan, epsilon |
2391 |
0.22 |
chr8_109244278_109244568 | 1.46 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
5443 |
0.3 |
chr7_99538268_99538788 | 1.46 |
Arrb1 |
arrestin, beta 1 |
1141 |
0.35 |
chr7_70253043_70253506 | 1.45 |
Gm29327 |
predicted gene 29327 |
3498 |
0.25 |
chr8_112572299_112572848 | 1.45 |
Cntnap4 |
contactin associated protein-like 4 |
2518 |
0.32 |
chr1_32173438_32173903 | 1.44 |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
783 |
0.74 |
chr18_57468245_57468987 | 1.44 |
Ctxn3 |
cortexin 3 |
94 |
0.97 |
chr13_34126566_34127191 | 1.43 |
Tubb2b |
tubulin, beta 2B class IIB |
3476 |
0.13 |
chr4_54073101_54073376 | 1.43 |
Gm24177 |
predicted gene, 24177 |
69181 |
0.11 |
chr3_54157562_54157856 | 1.43 |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
1094 |
0.64 |
chr13_48158648_48160003 | 1.41 |
Gm36346 |
predicted gene, 36346 |
77926 |
0.08 |
chr1_137262070_137262305 | 1.41 |
Gm37057 |
predicted gene, 37057 |
10045 |
0.23 |
chr7_48961270_48961876 | 1.40 |
Nav2 |
neuron navigator 2 |
2476 |
0.25 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.9 | 2.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.8 | 3.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 3.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.7 | 2.0 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.6 | 1.9 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 3.1 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.5 | 2.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.5 | 1.9 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.5 | 4.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.5 | 2.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.4 | 1.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.4 | 1.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.4 | 0.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.4 | 3.9 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.4 | 3.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.4 | 1.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.4 | 0.7 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.4 | 1.5 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 1.4 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.3 | 1.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.6 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.3 | 1.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 0.9 | GO:0042938 | dipeptide transport(GO:0042938) |
0.3 | 1.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.3 | 1.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.3 | 2.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.3 | 0.8 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 0.5 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 0.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 3.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 0.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 1.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.2 | 0.7 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.2 | 0.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.2 | 0.7 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 0.5 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.2 | 1.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 2.0 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 1.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.2 | 0.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 0.7 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.2 | 0.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.2 | 0.4 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.2 | 1.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 1.0 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.2 | 2.7 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 0.4 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 0.8 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.2 | 0.6 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.2 | 2.3 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.6 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 0.6 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.2 | 1.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 4.7 | GO:0001964 | startle response(GO:0001964) |
0.2 | 3.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 3.7 | GO:0035640 | exploration behavior(GO:0035640) |
0.2 | 0.2 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.2 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 3.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.5 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 0.5 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 0.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.5 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 0.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.2 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.2 | 0.2 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.2 | 1.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.2 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.2 | 4.3 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 0.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 0.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 0.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 0.5 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.8 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.8 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.2 | 1.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.2 | 0.5 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 1.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.3 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.4 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 1.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.4 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 1.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 0.3 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.1 | 0.4 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.4 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 1.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.6 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 0.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 2.6 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 0.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.1 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.1 | 2.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.9 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 1.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 3.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 1.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 3.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 1.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.3 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 0.2 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.2 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.1 | 0.7 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.3 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.1 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 1.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.3 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 5.4 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 0.2 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 3.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.5 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 1.9 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.7 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.3 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.1 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 1.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 1.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 6.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.2 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.8 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.4 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.1 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.1 | 0.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.3 | GO:0038107 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.1 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.2 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.2 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.1 | 0.2 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
0.1 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 0.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 1.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.4 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.2 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.2 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.1 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.1 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.1 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.0 | 0.0 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.0 | 0.0 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
0.0 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.0 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.2 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.1 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.5 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.0 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.0 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
0.0 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:1902991 | regulation of amyloid precursor protein catabolic process(GO:1902991) |
0.0 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.1 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 2.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.4 | GO:0043217 | myelin maintenance(GO:0043217) |
0.0 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.6 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.2 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.0 | 0.0 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.0 | 0.1 | GO:0072017 | distal tubule development(GO:0072017) |
0.0 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.7 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.0 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.0 | 0.6 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.0 | 0.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.0 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.0 | 0.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.0 | 0.3 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.1 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.1 | GO:0034776 | response to histamine(GO:0034776) |
0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.0 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.0 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.4 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.0 | 1.7 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.2 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.0 | 1.6 | GO:0007411 | axon guidance(GO:0007411) |
0.0 | 0.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.2 | GO:0021766 | hippocampus development(GO:0021766) |
0.0 | 0.0 | GO:0061549 | noradrenergic neuron development(GO:0003358) sympathetic ganglion development(GO:0061549) |
0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.1 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.1 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.0 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
0.0 | 0.0 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.0 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.0 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.0 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.0 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.0 | 0.0 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.1 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.0 | 0.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.2 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.0 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.2 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.0 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.0 | 0.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.0 | 0.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.0 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.0 | 0.0 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.0 | 0.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.3 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.0 | 0.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.0 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.0 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.0 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.1 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.0 | 0.0 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.0 | 0.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.0 | 0.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 0.0 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.0 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 1.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 3.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 0.7 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 2.2 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 2.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.3 | 0.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.3 | 4.1 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 0.8 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 1.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 1.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 1.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 1.6 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 2.8 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 8.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 2.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 1.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.7 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 1.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 1.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.2 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 5.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 1.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 10.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 6.5 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 3.0 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 10.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.4 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 2.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 1.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.0 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.7 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 9.7 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 1.0 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 1.6 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.7 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.1 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.0 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 2.1 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.2 | 3.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 4.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.8 | 2.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.7 | 1.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.6 | 1.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 1.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 1.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.4 | 2.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 1.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 1.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 1.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.3 | 1.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 1.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 0.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 0.8 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 0.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 2.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 1.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 0.6 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 2.6 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 1.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 1.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 0.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 0.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.5 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 1.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 4.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 1.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 1.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.5 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 1.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.1 | 3.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 4.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 3.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 1.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 3.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 2.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 1.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 1.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 1.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 1.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 2.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.5 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 2.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 0.4 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 2.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 1.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 0.9 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.2 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.9 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.0 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 1.9 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.8 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 1.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.0 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.3 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.0 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.4 | GO:0052693 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 3.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 1.2 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.0 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 1.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 6.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 5.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 4.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 3.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 1.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 3.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 0.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 5.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 3.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 5.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 1.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 0.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 2.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 1.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 3.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 4.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 2.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 2.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 2.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 3.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 1.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.0 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.5 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |